1 / 3

Design of Perinatal and Ongoing Infant Trials for Maternal and Child Health Studies

A comprehensive overview of completed and ongoing trials focusing on maternal and infant health interventions in various countries.

cheng
Download Presentation

Design of Perinatal and Ongoing Infant Trials for Maternal and Child Health Studies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Design of Completed Perinatal Trials AP IP PP (baby, mother or both) 14 wks 28 wks 36 wks 3d to 1 wk 6 wks 076 NonBF Thai (Harvard) NonBF Thai (Harvard) NonBF Thai (Harvard), BMS NonBF IvC (ANRS), PETRA, Thai (Harvard) BF/NonBF Thai (CDC), IvC (CDC) NonBF/BF PETRA,012, SAINT BF PETRA BF Wade (observational) NonBF

  2. Design of Ongoing/Planned Infant Prophylaxis Trials AP IP PP infant 34 wks 36 wks 1 wk 4 wks 6 wks 6 mo 3d PP infant regimen Botswana (Harvard) AZT +/- NVPx1 SIMBA AZT/DDI + NVP vs 3TC HPTN 046 NVP (daily) vs NVPx1 Ethiopia/India NVP(daily) vs NVPx1 NICHD/HPTN 040(Brazil) AZT vs NPV; AZT vs AZT + NVPx3 vs AZT + 3TC/NFV 2wk Thai (CDC) AZT + NVPx1 Thai (Harvard)/ AZT +/- NVPx1 Ivory Coast (ANSR) AZT + NVPx1 Malawi NVPx1 vs NVPx1 + AZT Zambia (Harvard) South Africa HIVNET 024 Uganda Zambia (UAB/PAF)/ HPTN 054 NVPx1+EBF abrupt vs routine wean; NVPx1+EBF NVPx1 + AP/IP antiobiotics vs no antibiotics NVPx1 vs NVPx1 + HIVIG +/- VCT NVPx1

  3. Design of Maternal HAART Prophylaxis Trials PP maternal regimen AP IP PP Mother ?? wks 36 wks 6 mos ?? mo Botswana (Harvard) AZT/3TC/NVP? MTCT-Plus AZT/3TC/NFV? Kenya (CDC) HAART x 6 months AZT/3TC/NFV (?) vs NVP infant x 6 mos vs NVPx1 + nutrition Malawi (CDC/UNC) Cameroon (EGPAF) HAART during BF Multisite Africa (WHO) AP if CD4> 200: AZT VS HAART; IP: ZDV vs HAART PP: NO ARV vs HAART

More Related